Abstract：
This study aimed to assess the current management of melanoma from relative to present guidelines and determine changes 5 years ago. An eight-question survey was sent to practicing US dermatologists using the same methodology and questions from our JAAD study. Overall, saucerization/scoop biopsy (48%) was the most commonly used method. The most commonly chosen margin for melanoma in-situ (MMIS) removal was 6-10 mm (51% of respondents). For CMM with a depth greater than 1 mm, the most commonly chosen margins were in the 1.1-1.9 cm range (55% of respondents). More respondents referred cases of MMIS and CMM out for treatment as compared to 2016. Academic dermatologists in 2021 were 8% less likely to treat MMIS as compared to all other practice types in 2021, whereas 7% more likely to treat CMM greater than 1 mm. Academic dermatologists in 2016, as compared to 2021, were 4% more likely to treat MMIS and 19% more likely to treat CMM greater than 1 mm. A total of 91% of respondents reported having some change in their management of CMM. Our study findings suggest that a knowledge gap still exists representing a continued educational opportunity to more effectively distribute and implement CMM management guidelines.
摘要：
这项研究旨在从相对于目前的指南评估黑色素瘤的当前管理，并确定5年前的变化。使用与JAAD研究相同的方法和问题，向执业的美国皮肤科医生发送了八个问题的调查。总的来说,最常用的方法是烤盘化/勺活检（48％）。最常选择的原位黑色素瘤（MMIS）切除边缘是6-10毫米（51％的受访者）。对于深度大于1mm的坐标测量机，最常选择的边缘在1.1-1.9cm范围内(55%的受访者).与2016年相比，更多的受访者将MMIS和CMM病例转诊为治疗。与2021年的所有其他实践类型相比，2021年的学术皮肤科医生治疗MMIS的可能性要低8％，而治疗大于1毫米的CMM的可能性要高7％。与2021年相比，2016年的学术皮肤科医生治疗MMIS的可能性增加了4％，治疗大于1毫米的CMM的可能性增加了19％。共有91％的受访者表示他们的CMM管理发生了一些变化。我们的研究结果表明，知识差距仍然存在，这代表了持续的教育机会，可以更有效地分发和实施CMM管理指南。
